Related Experiment Video
Updated: Aug 14, 2025
Implantation of Miniosmotic Pumps and Delivery of Tract Tracers to Study Brain Reorganization in Pathophysiological Conditions
Published on: January 18, 2016
The Development of Drug Delivery Systems for Efficient Intracranial Hemorrhage Therapy
Wenyan Yu1,2,3, Bingbing Liu1, Lei Zhou1
1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Insights
Intracerebral hemorrhage (ICH) treatment faces challenges with traditional methods. Advanced drug delivery systems show promise for improved ICH therapy by enhancing drug efficacy and reducing side effects.
Area of Science:
- Neurology
- Biomedical Engineering
- Pharmacology
Background:
- Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality.
- Current treatments like surgery and conventional drugs have limited efficacy and practicality.
- Understanding ICH pathology is crucial for developing better therapeutic strategies.
Purpose of the Study:
- To review the molecular pathological mechanisms of ICH.
- To discuss the limitations of traditional pharmacotherapy for ICH.
- To highlight advancements in drug delivery systems for ICH treatment.
Main Methods:
- Comprehensive review of existing literature on ICH pathology and treatment.
- Analysis of traditional pharmacotherapy approaches and their drawbacks.
- Exploration of drug delivery systems' potential in ICH management.
Main Results:
- Drug delivery systems offer improved pharmacokinetics and targeted accumulation for ICH treatment.
- These systems enhance therapeutic effects while minimizing toxicity.
- Significant limitations exist in current drug delivery system applications for ICH.
Conclusions:
- Drug delivery systems represent a promising avenue for overcoming the limitations of traditional ICH therapies.
- Further research is needed to address the challenges and optimize drug delivery systems for clinical application in ICH.
- Developing novel drug delivery strategies is essential for a feasible path toward effective ICH treatment.
Abstract:
Intracerebral hemorrhage (ICH) is the most devastating form of stroke, which accounts for 10-15% of cases and causes high morbidity and mortality. With the continuous exploration of the pathological mechanism of ICH, extensive research focusing on ICH therapy has been conducted. However, the traditional treatment methods, such as surgery for removing the hematoma and pharmacotherapy for improving the clearance of the hematoma and neuroprotection, are greatly limited due to their poor practicality and treatment efficiency. The rapid development of drug delivery systems offers an important prospect for treating ICH as they exhibit great versatility, which can improve the pharmacokinetic behavior of drugs in vivo, increase the drug accumulation in specific cell types or tissues, and enhance the therapeutic effect with diminished toxic effect. In this review, the main molecular pathological mechanisms of ICH are comprehensively described and the limitation of traditional pharmacotherapy are also discussed. Then the development based on drug delivery systems for treating ICH is highlighted. Finally, based on these discussions the challenges of drug delivery systems with a view to providing a new feasible path for the treatment of ICH are summarized.
Related Concept Videos
01:29Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:22Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...